International Conference on HIV and Vaccine Research

ICHVR

3rd Nov – 4th Nov 2026 Barcelona, Spain

Official Invitation Letter Available

An official invitation letter will be provided upon successful registration for your participation in the conference.

Benefits of Registering as Listener

Access to All Conference Sessions

Plenary, keynote and parallel sessions

Networking Opportunities

Connect with global educators & researchers

Certificate of Participation

Digital certificate of participation

Invitation Letter Support

Official invitation letter after successful registration

Conference Kit / Digital Materials

E-proceedings & resource materials

Access to Keynote Sessions

Learn from leading experts & scholars

Credit Card

Debit Card

Net Banking

Cash Card

Unified Payments

Select Registration Mode

Standard / Physical Participation USD

Join us on-site for keynotes, talks, workshops, networking, conference kit and certificate.

Virtual Participation USD

Participate online via live streaming. Includes live access to all sessions, digital materials and certificate.

Participant Details

Full Name *

Email Address *

Mobile Number with Country Code *

City *

State *

Country *

Zip / Postal Code *

Address *

Coupon Code

Terms & Condition

I agree to the Terms & Conditions and Refund & Cancellation Policy.

Read the full Terms & Conditions

Registration Summary

Conference ICHVR

Date 3rd Nov – 4th Nov 2026

Location Barcelona, Spain

Participation Type Listener

Organizer Science Leagues

Registration Mode Standard / Physical

Registration Fee USD 0.00

Bank Convenience Charges (5.8%)i USD 0.00

Calculated based on 5.8% of the registration fee

Discount USD 0.00

Total Payable USD 0.00

100% Secure Payment

Your payment information is encrypted and processed securely.

Conference Session Tracks

Aligned with UN Sustainable Development Goals

The conference's session tracks effectively support the following SDGs.

01 Advancements in HIV Vaccine Development +

This track focuses on the latest breakthroughs in HIV vaccine research, including novel approaches and technologies. Participants will explore the implications of these advancements for future vaccine efficacy and accessibility.

SDG 3 SDG 4

02 Immunological Responses to HIV Vaccines +

This session will delve into the immunological mechanisms underlying responses to HIV vaccines. Discussions will include the role of various immune cells and the impact of these responses on vaccine design.

SDG 3 SDG 4

03 Clinical Trials in HIV Vaccine Research +

This track will review the design, implementation, and outcomes of recent clinical trials for HIV vaccines. Participants will analyze challenges faced and lessons learned in the pursuit of effective vaccination strategies.

SDG 3 SDG 9

04 Molecular Diagnostics in HIV Management +

This session will cover the latest advancements in molecular diagnostic techniques for HIV detection and monitoring. Emphasis will be placed on the integration of these technologies into clinical practice.

SDG 3 SDG 4

05 Translational Research in HIV Vaccine Development +

This track will highlight the importance of translational research in bridging laboratory findings with clinical applications in HIV vaccine development. Participants will discuss strategies to enhance the translation of research into effective interventions.

SDG 3 SDG 9

06 Therapeutic Innovations for HIV Treatment +

This session will explore novel therapeutic approaches and innovations in the treatment of HIV. Discussions will focus on combination therapies, long-acting formulations, and personalized medicine.

SDG 3 SDG 4

07 Laboratory Techniques in HIV Research +

This track will provide insights into cutting-edge laboratory techniques employed in HIV research. Participants will learn about methodologies that enhance the understanding of HIV pathogenesis and vaccine responses.

SDG 3 SDG 4

08 Community Interventions for HIV Prevention +

This session will examine effective community-based interventions aimed at preventing HIV transmission. Participants will discuss the role of education, outreach, and local engagement in enhancing public health outcomes.

SDG 3 SDG 4

09 Public Health Strategies in HIV Control +

This track will focus on the development and implementation of public health strategies to control HIV spread. Discussions will include policy frameworks, resource allocation, and the role of healthcare systems.

SDG 3 SDG 4

10 Ethical Considerations in HIV Vaccine Research +

This session will address the ethical challenges and considerations inherent in HIV vaccine research and clinical trials. Participants will engage in discussions about informed consent, equity, and the responsibilities of researchers.

SDG 3 SDG 16

11 Global Perspectives on HIV Vaccine Research +

This track will provide a platform for discussing global initiatives and collaborations in HIV vaccine research. Participants will explore the impact of cultural, economic, and political factors on vaccine development and distribution.

SDG 3 SDG 17